Speaker illustration

Professor John Mcneil

Monash University, Melbourne (Australia)

After graduating in medicine from the University of Adelaide John McNeil undertook specialist training to become qualified as a consultant in internal medicine and clinical pharmacology. He completed a PhD in Clinical Pharmacology at Melbourne University. He headed the Monash University Department (&subsequently School) of Public Health & Preventive Medicine from 1986-Jan 2019, developing a core of methodological skills in epidemiology, clinical medicine, bio statistics & data-management. His principal research interest is in large community-based intervention trials and was the initiator of the ASPREE trial. His other interest is clinical registry science

Should my grandmother be on aspirin? Lessons from ASPREE, ADVANCE and ASCEND.

Event: ESC CONGRESS 2019

Topic: Risk Factors and Prevention

Session: Would you give it to your grandmother? - Primary prevention in the elderly

Thumbnail

Aspirin for the Primary Prevention of Cardiovascular Disease – Represented in NEJM by the ASPREE and ASCEND trials (and in Lancet by the ARRIVE trial).

Event: ESC CONGRESS 2019

Topic: European Society of Cardiology

Session: Highlights from the New England Journal of Medicine: editors’ choice

Thumbnail

ESC 365 is supported by

logo Novo Nordisk